a
a
Weather:
No weather information available
HomeHealthCollPlant Biotechnologies Provides a Corporate Update

CollPlant Biotechnologies Provides a Corporate Update

– Additional patent granted for photocurable dermal filler – Update on AbbVie dermal filler program and achievement of contingent payment – Plan for cost reductions in place to extend cash runway REHOVOT, Israel, Feb. 12, 2025 /PRNewswire/ — CollPlant Biotechnologies (NASDAQ: CLGN), or…

No comments

Sorry, the comment form is closed at this time.

Translate »